« Back
Home /
SB202190

SB202190

Item no.	TMO-T2301-2mg
Manufacturer	TargetMol
CASRN	152121-30-7
Amount	2mg
Quantity options	100mg 10mM*1mL(inDMSO) 10mg 1ml 200mg 25mg 2mg 50mg 5mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,98
ECLASS 5.1	32169090
ECLASS 6.1	32169090
ECLASS 8.0	32169090
ECLASS 9.0	32169090
ECLASS 10.0.1	32169090
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	SB 2219, SB2219; SB-2219, p38 MAPK inhibitor
Similar products	152121-30-7
Available
Description	SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38alpha/beta with IC50 of 50 nM/100 nM in cell-free assays, sometimes used instead of SB 203580 to investigate potential roles for SAPK2a/p38 in vivo.
Formulate	C20H14N3OF
Shipping temperature	Cool Pack
Smeles	FC1=CC=C(C=C1)C1=C(NC(N1)=C1C=CC(=O )C=C1)C1=CC=NC=C1
Storage Temperature	-20° C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2mg

available

Delivery expected until 8/9/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail